- Home
- CGON vs LILA Comparison
CGON vs LILA Comparison
Compare CGON & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- LILA
- Stock Information
- Founded
- CGON 2010
- LILA 2017
- Country
- CGON United States
- LILA Bermuda
- Employees
- CGON N/A
- LILA N/A
- Industry
- CGON
- LILA Cable & Other Pay Television Services
- Sector
- CGON
- LILA Telecommunications
- Exchange
- CGON NYSE
- LILA Nasdaq
- Market Cap
- CGON 1.3B
- LILA 1.1B
- IPO Year
- CGON 2024
- LILA N/A
- Fundamental
- Price
- CGON $25.62
- LILA $4.91
- Analyst Decision
- CGON Strong Buy
- LILA Buy
- Analyst Count
- CGON 10
- LILA 2
- Target Price
- CGON $64.00
- LILA $7.90
- AVG Volume (30 Days)
- CGON 1.4M
- LILA 717.5K
- Earning Date
- CGON 05-13-2025
- LILA 05-07-2025
- Dividend Yield
- CGON N/A
- LILA N/A
- EPS Growth
- CGON N/A
- LILA N/A
- EPS
- CGON N/A
- LILA N/A
- Revenue
- CGON $662,000.00
- LILA $4,441,000,000.00
- Revenue This Year
- CGON N/A
- LILA $3.30
- Revenue Next Year
- CGON $12,387.03
- LILA $3.11
- P/E Ratio
- CGON N/A
- LILA N/A
- Revenue Growth
- CGON 224.51
- LILA N/A
- 52 Week Low
- CGON $14.80
- LILA $4.26
- 52 Week High
- CGON $40.47
- LILA $10.82
- Technical
- Relative Strength Index (RSI)
- CGON 53.27
- LILA 42.45
- Support Level
- CGON $24.79
- LILA $4.83
- Resistance Level
- CGON $26.60
- LILA $5.18
- Average True Range (ATR)
- CGON 1.39
- LILA 0.24
- MACD
- CGON -0.01
- LILA 0.02
- Stochastic Oscillator
- CGON 48.52
- LILA 52.29
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.